
The Central Drugs Standard Control Organization (CDSCO), India’s apex drug regulator, has identified 203 specific formulations including antibiotics, insulin preparations, vaccines, toxoid, human blood products and plasma that require this strict control. This assumes significance for India’s $12 billion biopharmaceutical market, with India supplying 60% of vaccines to more than 200 countries.





